PomDoctor
General Information | |
Business: | We run an online platform in China to provide chronic disease management services. (Incorporated in the Cayman Islands) As of Dec. 31, 2024, PomDoctor had over 212,800 doctors (under contract) who had issued about 3.13 million prescriptions. The company had 699,000 patients (also referred to as transacting patients) as of Dec. 31, 2024. Our mission is to provide effective prevention and treatment solutions to alleviate patients’ suffering from illnesses. Our vision is to become the most trustworthy medical and healthcare services platform. We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan. With focuses on chronic disease management and pharmaceutical services, our business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Our experience in tackling chronic diseases can be traced back to 2015 when we launched our platform on mobile devices. We strategically chose to focus on this field because chronic diseases last at least one year by definition, and they are hard to cure, prone to complications and require ongoing medical attention. As such, patients with chronic diseases have a great and relatively inelastic demand for frequent and repeat follow-up visits and of drug purchases, which gives a competitive advantage to platforms that are able to maintain long-term, stable doctor-patient relationships.
Note: Net loss and revenue are in U.S. dollars (converted from China’s currency) for the year that ended Dec. 31, 2024. (Note: PomDoctor disclosed its IPO’s terms in an F-1/A filing dated July 15, 2025: The company is offering 5.0 million American Depositary Shares (ADS) at a price range of $4.00 to $6.00 to raise $25 million, if the IPO is priced at the $5.00 mid-point of its range. Background: PomDoctor filed its F-1 on March 13, 2025, without disclosing the terms for its IPO. and disclosed the terms for its IPO.) |
Industry: | Online medical services platform |
Employees: | 156 |
Founded: | 2010 |
Contact Information | |
Address | Yongxu Industrial Park No.19-23 Hejing Road, Dongsha Street Liwan District, Guangzhou 510000 People’s Republic of China |
Phone Number | +86 020-6231 2277 |
Web Address | http://www.7lk.com/ |
View Prospectus: | PomDoctor |
Financial Information | |
Market Cap | $592.0mil |
Revenues | $46.93 mil (last 12 months) |
Net Income | $-5.12 mil (last 12 months) |
IPO Profile | |
Symbol | POM |
Exchange | NASDAQ |
Shares (millions): | 5.0 |
Price range | $4.00 - $6.00 |
Est. $ Volume | $25.0 mil |
Manager / Joint Managers | Joseph Stone Capital/Uphorizon |
CO-Managers | |
Expected To Trade: | |
Status: | TBA |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |